Be part of the knowledge.™

Oncology and Hematology

1515

LikeLikedUnlike

16-30 of 811

How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Project Oncology®
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
- Ryan Quigley
  Peer
Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management
Heart Matters
Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management
- Saurabh Malhotra, MD, MPH, FASNC
  Peer
- Cigdem Akincioglu, MD, FASNC
  Peer
- Kevin Alexander, MD
  Peer
- Katherine Lee Chuy, MD
  Peer
- Angela Dispenzieri, MD
  Peer
- Sharmila Dorbala, MD, MPH, MASNC
  Peer
- Cesia Gallegos-Kattán, MD, MHS, FASNC
  Peer
- Wael Jaber, MD, FASNC
  Peer
- Mike Lane
  Peer
- Ahmad Masri, MD, MS
  Peer
- Mathew S. Maurer, MD
  Peer
- Frederick Ruberg, MD
  Peer
- Prem Soman, MD, PhD, MASNC
  Peer
- Brett Sperry, MD, FASNC
  Peer
- Andrew Staron, MD
  Peer
- Jonathan Wall, PhD
  Peer
- Ashutosh Wechalekar, MBBS, MD
  Peer
- David Wolinsky, MD, MASNC
  Peer
- Sasha Zivkovic, MD, PhD
  Peer
- A Sami Abuzaid, MD, FASNC
  Peer
- Vasvi Singh, MD, FASNC
  Peer
- Mark Hyun, CNMT, NCT, RS, RT(N,R,CT), FASNC
  Peer
- Maria Mackin, BS, MS, CNMT, RT (N), LNMT, FASNC
  Peer
- Ronald G. Schwartz, MD, MS, MASNC
  Peer
Applying Real-World Data from SABCS 2025 to HR+ HER2- Breast Cancer Care
Project Oncology®
Applying Real-World Data from SABCS 2025 to HR+ HER2- Breast Cancer Care
- Pavani Chalasani, MD, MPH
  Peer
- Virginia Borges, MD
  Peer
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Project Oncology®
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Project Oncology®
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Predicting Breast Cancer Metastasis with Proteomics
Project Oncology®
Predicting Breast Cancer Metastasis with Proteomics
advertisement
Does BMI Matter in mBC Outcomes?
Project Oncology®
Does BMI Matter in mBC Outcomes?
Advancing HER2-Targeted Therapy in GI Cancers
Project Oncology®
Advancing HER2-Targeted Therapy in GI Cancers
- John H. Strickler, MD
  Peer
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
On the Frontlines of Metastatic Breast Cancer
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Heather Parsons
  Peer
How AI Is Transforming Biomarker Development in GI Oncology
Project Oncology®
How AI Is Transforming Biomarker Development in GI Oncology
- William Hall, MD
  Peer
Surgical Insights on Gastroesophageal Cancer: Balancing Surveillance and Intervention
Project Oncology®
Surgical Insights on Gastroesophageal Cancer: Balancing Surveillance and Intervention
- Daniela Molena, MD
  Peer
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Project Oncology®
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
advertisement
The Next Chapter: SABCS 2025 and the Future of HR+ HER2− Breast Cancer Care
Project Oncology®
The Next Chapter: SABCS 2025 and the Future of HR+ HER2− Breast Cancer Care
- Pavani Chalasani, MD, MPH
  Peer
- Alison Stopeck, MD
  Peer
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
On the Frontlines of Metastatic Breast Cancer
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
- Ashley Baker, MSN, PMHNP
  Peer
- Nick McAndrew, MD, MSCE
  Peer
Exploring T-DXd in HER2-Positive Breast Cancer Treatment
On the Frontlines of Metastatic Breast Cancer
Exploring T-DXd in HER2-Positive Breast Cancer Treatment
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Jules Cohen, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended